| 1 |
29298688 | Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations. | 2018 Jan 3 |
2 |
| 2 |
30028120 | Overcoming Chemoresistance in Cancer via Combined MicroRNA Therapeutics with Anticancer Drugs Using Multifunctional Magnetic Core-Shell Nanoparticles. | 2018 Aug 15 |
1 |
| 3 |
28471200 | [Fullerene Doxorubicin Nanotransporter for Target Interaction with mutated gene BRCA2]. | Spring 2017 |
1 |
| 4 |
28626402 | Effect of the Combination of Trabectedin and Pegylated Liposomal Doxorubicin in a BRCA2 Mutation Carrier with Recurrent Platinum-Sensitive Ovarian Cancer. | 2017 May-Aug |
1 |
| 5 |
14647413 | Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression. | 2004 Jan 29 |
1 |
| 6 |
15280929 | Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI). | 2004 Aug 16 |
1 |
| 7 |
12591928 | p53 mediates repression of the BRCA2 promoter and down-regulation of BRCA2 mRNA and protein levels in response to DNA damage. | 2003 May 2 |
5 |
| 8 |
11295099 | Regulation of BRCA1 and BRCA2 transcript in response to cisplatin, adriamycin, taxol and ionising radiation is correlated to p53 functional status in ovarian cancer cell lines. | 2001 May-Jun |
1 |
| 9 |
10344722 | Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells. | 1999 Jun 15 |
1 |
| 10 |
9619832 | Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. | 1998 Apr 30 |
6 |
| 11 |
9679765 | Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation. | 1998 Aug 12 |
2 |